Enter inventor name

San Rafael, CA, United States of America

Robert F Halenbeck

This inventor holds 40 USPTO granted patents, plus 1 CIPO patent, primarily in Protein Engineering. Top assignees: Chiron Corporation, Cetus Corporation, Cetus Oncology Corporation. Active years: 1986-2007.

USPTO Granted Patents = 40

% Patents Active = 95.0

CIPO Patents = 1

Average Co-Inventor Count = 4.8

ph-index = 12

Forward Citations = 1,016(Granted Patents)

Location History:

San Rafael, CA (US) (1986 - 2007)
San Rafeal, CA (US) (2007)

Company Filing History:

Cetus Oncology Corporation

Novartis Vaccines & Diagnostics, Gmbh

patents

6. 2 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1986-2007

Loading Chart...

Areas of Expertise:

Protein Purification

Recombinant Proteins

CSF-1 Dimer

Mac-2-binding Glycoprotein

Monoclonal Antibodies

Interleukin-2 Muteins

Cancer Therapeutics

Nucleic Acids

Point Mutants

Assay Methods

Oxidation-resistant Muteins

Disulfide Bond Formation

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7226757 - Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor (2007-06-05),

2. 7186530 - Protein associated with cell stress response (2007-03-06),

3. 7022672 - Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor (2006-04-04),

4. 6599706 - Recombinant PR-3 and assays employing the same (2003-07-29),

5. 6586222 - Recombinant PR-3 and compositions thereof (2003-07-01),

6. 6323326 - Method of solubilizing, purifying, and refolding protein (2001-11-27),

7. 6322779 - Recombinant human CSF-1 dimer and compositions thereof (2001-11-27),

8. 6319896 - Method of solubilizing, purifying, and refolding protein (2001-11-20),

9. 6204020 - DNA encoding N∇2 CSF-1 (short form) and carboxy truncated fragment thereof (2001-03-20),

10. 6156300 - Point mutants of N.gradient.2 CSF-1 and carboxy truncated fragments (2000-12-05),

11. 6146851 - DNA encoding NV2 (long form) and carboxy truncated fragments thereof (2000-11-14),

12. 6117422 - N.gradient.2-CSF-1(long form) and carboxy truncated fragments thereof (2000-09-12),

13. 6103224 - N.gradient.2 CSF-1 (short form) and carboxy truncated fragments thereof (2000-08-15),

14. 6069127 - Secreted mac-2-binding glycoprotein (2000-05-30),

15. 6025146 - Identification of M-CSF agonists and antagonists (2000-02-15),

Title: The Innovative Journey of Robert F. Halenbeck

Introduction: Robert F. Halenbeck, a pioneering inventor based in San Rafael, CA, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Robert F. Halenbeck holds several patents in various technological domains, showcasing his versatility and ingenuity in creating novel solutions to complex problems.

Career Highlights: Throughout his illustrious career, Robert F. Halenbeck has been at the forefront of technological advancements, consistently pushing the boundaries of innovation. His dedication to creating cutting-edge solutions has earned him recognition as a visionary in the industry.

Collaborations: Robert F. Halenbeck has collaborated with leading tech companies and research institutions, leveraging his expertise to drive collaborative projects that have resulted in groundbreaking inventions. His ability to work effectively in multidisciplinary teams has been instrumental in his success as an inventor.

Conclusion: In conclusion, Robert F. Halenbeck's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of technology. His remarkable inventions continue to inspire and shape the future of technological advancements.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]